| Date | Name | Title | Action | No Shares | Price Per Share |
|---|---|---|---|---|---|
Insider Transactions For VCYT | |||||
| 2025-11-10 | Wygant, Jonathan | VP, Chief Accounting Officer | Sold | 5102 | $42.33 |
| 2025-11-07 | Wygant, Jonathan | VP, Chief Accounting Officer | Sold | 5818 | $40.21 |
| 2025-11-05 | Jones, Evan/ Fa | Director | Sold | 24296 | $45.73 |
| 2025-11-05 | Eastham, Karin | Director | Sold | 9674 | $40.02 |
| 2025-11-05 | Jones, Evan/ Fa | Director | Purchased | 10000 | $7.94 |
| 2025-11-05 | Jones, Evan/ Fa | Director | Purchased | 10000 | $5.28 |
| 2025-11-05 | Jones, Evan/ Fa | Director | Sold | 408 | $41.74 |
| 2025-11-05 | Jones, Evan/ Fa | Director | Purchased | 10000 | $7.60 |
| 2025-11-05 | Jones, Evan/ Fa | Director | Sold | 10837 | $43.80 |
| 2025-11-05 | Jones, Evan/ Fa | Director | Sold | 5872 | $45.07 |
| 2025-11-05 | Chambers, Rebecca | Chief Financial Officer | Sold | 7000 | $41.00 |
| 2025-11-05 | Jones, Evan/ Fa | Director | Sold | 10000 | $0.00 |
| 2025-11-05 | Jones, Evan/ Fa | Director | Sold | 657 | $46.38 |
| 2025-11-05 | Mcguire, Annie | SVP, General Counsel | Sold | 6466 | $40.00 |
| 2025-11-05 | Jones, Evan/ Fa | Director | Sold | 1126 | $43.03 |
| 2025-10-28 | Wygant, Jonathan | VP, Chief Accounting Officer | Purchased | 2886 | $0.00 |
| 2025-10-06 | Febbo, Phillip G. | Chief Scientific & Med Officer | Sold | 8349 | $36.02 |
| 2025-10-01 | Epstein, Robert S | Director | Sold | 21473 | $35.08 |
| 2025-10-01 | Epstein, Robert S | Director | Sold | 10000 | $0.00 |
| 2025-10-01 | Leite, John | Chief Commercial Officer-CLIA | Sold | 2539 | $35.00 |